Close
ACHEMA MIDDLE EAST 2026

Animal Testing Could See An End With An Artificial Model

Uppsala University researchers have created an artificial blood-brain barrier model that can be used to assess the efficacy of anti-body-based medicines while reducing animal...

Hong Kong Gives $500mn Funding For Chinese Drug Development

The Hong Kong government announced plans to add $500 million to the Chinese Medicine Development Fund beginning with this fiscal year during a budget...

Germany Rolls First CAR-T Push For Muscle Inflammation Cure

One of the university hospitals in Germany was the first in the world to effectively treat a patient with a severe case of muscular...

More Monitoring Required of Institutional Review Boards

The Government Accountability Office has issued an analysis suggesting that the FDA should increase its oversight of institutional review boards (IRBs) to better protect...

Stroke Patients To Get A Relief With Spinal Cord Stimulation

A small clinical trial has suggested that spinal cord stimulation may help stroke patients regain movement in their limbs and hands. In an article...

Major Trial Reveals Simplified HIV Treatment Options Perfect

As per the results of international research, which has the distinction of being the world’s first study into second-line human immunodeficiency virus- HIV therapy,...

DNA Mutations Can Help Kidney Cancer Recurrence Be Assessed

One of the international studies on kidney cancer recurrence has found that physicians can forecast the likelihood of a disease returning by way of...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...